Trial Profile
Effect of gulcose-lowering agents on adipocytokine levels in patients with diabetes mellitus
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Oct 2018
Price :
$35
*
At a glance
- Drugs Ipragliflozin (Primary) ; Dipeptidyl peptidase 4 inhibitors; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Oct 2018 Status changed from recruiting to completed.
- 28 May 2015 New trial record